ERBB2 and breast cancer: For example, some studies have shown that the benefit of activity-induced risk reduction is predominately in triple negative breast cancer prevention, followed by luminal A subtype breast cancers as compared to luminal B, luminal B-like, or HER2-enriched cancers [7].